Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia
Authors:
- Richard OlsonRORichard Olson
- Lewis LefkowitzLLLewis Lefkowitz
- Linda LaubensteinLLLinda Laubenstein
- Paul BellmanPBPaul Bellman
- Bienvenido YangcoBYBienvenido Yangco
- Javier O. MoralesJMJavier O. Morales
- Robert MurphyRMRobert Murphy
- William PowderlyWPWilliam Powderly
- Terry F. PlasseTPTerry F. Plasse
- Kristen W. MosdellKMKristen W. Mosdell
- Kirk V. ShepardKSKirk V. Shepard
Open Access
- 1 July 1997
- journal article
- clinical trial
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 14 (1) , 7-14
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Hyperglycemia Induced by Megestrol Acetate in a Patient with AIDSAnnals of Pharmacotherapy, 1996
- Energy Expenditure and Wasting in Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1995
- Induction of Adrenal Suppression by Megestrol Acetate in Patients with AIDSAnnals of Internal Medicine, 1995
- Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDSJournal of Pain and Symptom Management, 1995
- Megestrol Acetate in Patients with AIDS and CachexiaAnnals of Internal Medicine, 1994
- Clinical risk factors for malnutrition in HIV-1-infected patientsAIDS, 1993
- Nutrition support and the human immunodeficiency virus (HIV)Parasitology, 1993
- Wasting in the Acquired Immunodeficiency SyndromeSeminars in Liver Disease, 1992
- Dronabinol effects on weight in patients with HIV infectionAIDS, 1992
- Recent clinical experience with dronabinolPharmacology Biochemistry and Behavior, 1991